Results 221 to 230 of about 47,203 (289)

Analytical method development and validation of a serum LC-MS/MS assay for 2 emerging synthetic cannabinoids: 5F-MDMB-PICA and MDMB-4en-PINACA. [PDF]

Medicine (Baltimore)
Akbaba M, Isir AB, İbili S, Yiğitsoy CE.   +3 more
europepmc   +1 more source

Curcumin in the Treatment of Various Diseases: Mechanism of Action, Bioavailability, Therapeutic Effects, and Current Clinical Trials

MedComm, Volume 7, Issue 11, November 2026.
Curcumin, a naturally occurring polyphenol, exhibits significant anti‐inflammatory and antioxidant capabilities. This review elucidates the specific molecular mechanisms by which curcumin exerts therapeutic effects on various diseases, including neurological disorders, cardiovascular diseases, cancers, inflammatory disorders, and autoimmune diseases ...
Lin Wang, Qifei Pan, Wenjuan Long, Xinyao Li, Jianqin Mao, Sitong Zhou, Zihui Wang, Xuelian Zou, Yuqing She, Mingqin Shi, Yang Zhou, Jiarong Du, Zhongyang Hu, Xiaoman Lv, Yishu Chen, Dongdong Qin   +15 more
wiley   +1 more source

Cannabis flower extracts as a multi-target agent in Alzheimer's disease: Inhibition of AChE, BChE, and BACE1 with cell-protective effects in a PC12 cell model. [PDF]

J Cannabis Res
Shitrit A, Khattib A, Khatib S.
europepmc   +1 more source

Society for Maternal‐Fetal Medicine Special Statement: Guidance to reduce racial disparities in substance use screening and biological testing in pregnancy at the delivery admission

Pregnancy, Volume 2, Issue 6, November 2026.
Abstract Substance use complicates upward of 10% of US pregnancies. The Society for Maternal‐Fetal Medicine, the American College of Obstetricians and Gynecologists, and the American Society of Addiction Medicine have jointly recommended universal screening for substance use during pregnancy using a validated tool, without recommending universal ...
Society for Maternal‐Fetal Medicine (SMFM), Jennifer J. M. Cate, Samuel T. Bauer, Niraj R. Chavan, Marc Parrish, Jessica Peterson, Dena Goffman, Christina Davidson, SMFM Patient Safety and Quality Committee   +8 more
wiley   +1 more source

Effect of solvent polarity on phenolic antioxidant extraction from <i>Cannabis sativa</i> L. leaves and inflorescences: mixture design optimization and HPLC-DAD/ESI-MS² profiling. [PDF]

RSC Adv
El Maabiche O, Benkirane C, El Ati R, Haddad Y, Fauconnier ML, Allai L, Mansouri F.   +6 more
europepmc   +1 more source

Dietary Echinacea purpurea Attenuates Oxidative Stress and Alters Cytokine Gene Expression Among Heat‐Stressed Broiler Chickens at High Altitude

Veterinary Medicine and Science, Volume 12, Issue 6, November 2026.
Dietary Echinacea purpurea (0.75%) alleviated oxidative stress (↓NO, ↓MDA) and selectively upregulated IL‐10 and IFN‐γ expression in heat‐stressed broilers at high altitude, shifting the cytokine balance toward an anti‐inflammatory state without affecting telomere length.
Shahab Bahadoran, Shadi Vaeznia, Hossein Hassanpour   +2 more
wiley   +1 more source

Cannabinoids and opioid consumption in cancer pain: a systematic review and meta-analysis. [PDF]

Support Care Cancer
Creangă-Murariu I, Alexa-Stratulat T, Rusu MI, Chiru S, Dascalu C, Dobre CE, Tamba BI.   +6 more
europepmc   +1 more source

Prevalence of novel psychoactive substances in selected clinical urine specimens submitted for drug monitoring

Journal of Forensic Sciences, Volume 71, Issue 6, Page 2889-2899, November 2026.
Abstract Novel psychoactive substances (NPS) are compounds emerging as alternatives to more established drugs of abuse. They are constantly changing and being modified, which makes their detection difficult. The study objective was to determine the prevalence of NPS in selected clinical specimens. Deidentified urine specimen remnants were analyzed that
Jillian R. Neifeld, Theresa M. Meli, Sarah H. Bartock   +2 more
wiley   +1 more source

Global Prognostic Impact of Substance Use in Alcohol‐Associated Hepatitis

Alcohol, Clinical and Experimental Research, Volume 50, Issue 11, November 2026.
Alcohol‐associated hepatitis (AH) carries high short‐term mortality, yet behavioral risk factors are not captured by current prognostic models. In this multinational cohort of 814 patients, active cannabis use independently predicted mortality after accounting for liver disease severity and transplantation as a competing‐risk.
Omar Albhaisi, Francisco Idalsoaga, Wei Wang, Roberta C. Araujo, Guilherme Massote Fontanini, Arun Valsan, Gowripriya Nair, Bastián Alcayaga, Jorge Arnold, María Ayala‐Valverde, Carolina Ramirez‐Cadiz, Hanna Blaney, Vinay Jahagirdar, Hyundam Gu, S. Fisher Rhoads, Ximena Parraga, Butros Fakhoury, Prasun K. Jalal, Mohamad Ali Ibrahim, Mohamad A. Elfeki, Juan Pablo Roblero, Daniela Simian, José Antonio Velarde‐Ruiz Velasco, Jacqueline Córdova, Fátima Higuera‐de‐la‐Tijera, Rita Silva, Cristina Melo Rocha, Gustavo Henrique Pereira, Fernando Bessone, Mario Tanno, Ayelen Kisch, Manuel Mendizabal, Sebastián Marciano, Gonzalo Gomez Perdiguero, Pedro Montes, Patricia Guerra Salazar, Geraldine Ramos, Enrique Carrera, Lamia Haque, Kristina R. Chacko, Lubomir Skladaný, Arun J. Sanyal, Vijay H. Shah, Patrick S. Kamath, Marco Arrese, Winston Dunn, Ashwani K. Singal, Ramon Bataller, Luis Antonio Díaz, Juan Pablo Arab   +49 more
wiley   +1 more source